Simultaneous UV-spectrophotometric estimation of rosuvastatin and ezetimibe in their combined dosage forms

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 1, 2010, Pages 131-138

  Anuradha K , Gajjar ^a   Vishal D , Shah ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Ezetimibe; Rosuvastatin; UV spectrophotometric

Indexed keywords

EZETIMIBE; METHANOL; ROSUVASTATIN;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; DRUG ABSORPTION; DRUG DETERMINATION; QUALITY CONTROL; TABLET FORMULATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 77953427825     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lennernas H, Fager G. Pharmacodynamic and pharmacokinetics of the HMG-CoA reductase inhibitors. Clin Pharmacokinet 1997; 32:403-425.
2. Nissen S, Nicholls S, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295(13):1556-1565.
3. Leitersdorf E. Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management. Int J Clin Pract 2002; 56:116-119.
4. Heek MV, Farley C, Compton D, Hoos L, Davis HR. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Phamacol 2001; 134(2):409-417.
5. Dujovne A, Ettinger MP, McNeer F, Lipka L, Lebeaut AP, Suresh R, et al. Efficacy and Safety of a Potent New Selective Cholesterol Absorption Inhibitor, Ezetimibe, in Patients With Primary Hypercholesterolemia. Am J Cardiol 2002; 90:1092-1097.
6. Kumar TR, Shitut NR, Kumar PK, Vinu MC, Kumar VV, Mullangi R, et al. Determination of Rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies. Biomed Chromatogr 2006; 20:881-887.
7. Vittal S, Kumar TR, Shitut NR, Vinu MC, Kumar VV, Mullangi R. Simultaneous quantitation of Rosuvastatin and Gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study. Biomed Chromatogr 2006; 20: 1252-1259.
8. Mehta TN, Patel AK, Kulkarni GM, Suubbaiah G, Determination of Rosuvastatin in the presence of its degradation products by a stability-indicating LC method. J AOAC Int 2005; 88(4):1142-1147.
9. Suslu I, Celebier M, Altnoz S. Determination of Rosuvastatin in Pharmaceutical Formulations by Capillary Zone Electrophoresis. Chromatographia 2007; 66:65-72.
10. Uyar B, Celebier M, Altinoz S. Spectrophotometric determination of Rosuvastatin calcium in tablets. Pharmazie 2007; 62:411-413.
11. Sane RT, Kamat SS, Menon SN, Inamdar SR, Mote MR. Determination of Rosuvastatin calcium in its bulk drug and pharmaceutical preparations by high-performance thin-layer chromatography. J Planar Chromatogr 2007; 18:194-198.
12. Sistla R, Tata VS, Kashyap YV, Chandrasekar D, Diwan PV. Development and validation of a reversed-phase HPLC method for the determination of Ezetimibe in pharmaceutical dosage forms. J Pharm Biomed Anal 2005; 39:517-522.
13. Akmar SK, Kothapalli L, Thomas A, Jangam S, Deshpande AD. Reverse Phase HPLC method for the estimation of Ezetimibe in bulk and pharmaceutical formulations. Indian J Pharm Sci 2007; 69(5):695-697.
14. Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R. Stress degradation studies on Ezetimibe and development of a validated stability-indicating HPLC assay. J Pharm Biomed Anal 2006; 41:1037-1040.
15. Doshi AS, Kachhadia PK, Joshi H. Validation of a stability-indicating LC method for assay of Ezetimibe in tablets and for determination of content uniformity. Chromatographia 2008; 67:137-142.
16. Oswald S, Scheuch E, Cascorbi I, Siegmund W. A LC-MS/MS method to quantify the novel cholesterol lowering drug Ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 830:143-150.
17. Li S, Liu G, Jia J, Li X, Yu CJ. Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of Ezetimibe in human plasma. J Pharm Biomed Anal 2006; 40(4):987-992.
18. Jain N, Jain R, Swami H, Pandey S, Jain DK. Spectrophotometric method for simultaneous estimation of Simvastatin and Ezetimibe in bulk drug and its combined dosage form. Int J Pharm Pharm Sci 2009; 1(1):170-175.
19. Chaudhari BG, Patel MN, Shah PB, Patel LJ, Patel VP. Stability-indicating reversed-phase liquid chromatography method for simultaneous determination of Atrovastatin and Ezetimibe from their combination drug products. J AOAC Int 2007; 90(6):1539-1546.
20. Chaudhari BG, Patel NM, Shah PB. Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of Simvastatin and Ezetimibe from their combination drug products. J AOAC Int 2007; 90(5):1242-49.
21. Pernarowski M, Kneval AM, Christian JE. Application of absorbency ratios to the analysis of pharmaceuticals I. Theory of the analysis of binary mixtures. J Pharm Sci 1960; 50(11): 943.
22. Ghanem A, Meshali M. Foda A. Simultaneous spectrophotometric determination of trimethoprim and sulphamethoxazole in pharmaceutical preparations. J Pharm Pharmcol 1979; 31(2):122-123.
23. Erk N. Three new spectrophotometric methods applied to the simultaneous determination of Hydrochlorothiazide and Irbesartan. Pharmazie 2003; 58(8):543-8.
24. Ojeda CB, Rojas FS. Recent developments in derivative ultraviolet/visible absorption spectrophotometry. Anal Chim Acta 2004; 518:1-24.
25. Ewing GW. Instrumental methods of chemical analysis. Singapore: McGraw-Hil; 1985. p. 51
26. 2B, Geneva, Switzerland: 1996.